Literature DB >> 24291759

In vitro evaluation of the safety and probiotic properties of Lactobacilli isolated from chicken and calves.

Dobroslava Bujnakova1, Eva Strakova2, Vladimir Kmet1.   

Abstract

A total of 73 chicken and calves isolates were diagnosed using matrix-assisted laser desorption ionization-time-of flight mass spectrometry (Maldi-Tof MS). After a preliminary subtractive screening based on the high acid tolerance at pH 2.5 and bile resistance at 0.3% oxgall, twenty isolates belonging to the species Lactobacillus salivarius, Lactobacillus agilis, Lactobacillus reuteri, Lactobacillus murinus and Lactobacillus amylovorus were in vitro screened for the safety assessment and probiotic properties, including antibiotics susceptibility patterns, biochemical activity and potential for competitive exclusion of biofilm producing pathogens determined by crystal violet and/or quantitative Fluorescent in situ Hybridisation (FISH) assays utilizing 5'Cy 3 labelled probe Enter1432 for enteric group. Antibiotic susceptibility testing was performed according to the ISO norm 10932. The sixteen strains were susceptible to certain antimicrobial agents, except for two chicken (L. salivarius 12K, L. agilis 13K) and two calves (L. reuteri L10/1, L. murinus L9) isolates with the presence non wild-type ECOFFs (epidemiological cut-off) for gentamicin (≥256 μg ml(-1)), tetracycline (≥128 μg ml(-1)), kanamycin (≥256 μg ml(-1)) and streptomycin (≥96 μg ml(-1)). The two referenced chicken isolates gave positive aac(6')Ie-aph(2″)Ia and tet(L) PCR results. The wild-type ECOFFs isolates were subjected to the apiZYM analysis for enzyme profile evaluation and amino acid decarboxylase activities determined by qualitative plate method and multiplex PCR for the detection of four genes involved in the production of histamine (histidine decarboxylase, hdc), tyramine (tyrosine decarboxylase, tyrdc) and putrescine (via eithers ornithine decarboxylase, odc, or agmatine deiminase, agdi). From examined strains only two chicken isolates (L. reuteri 14K; L. salivarius 15K) had no harmful β-glucuronidase, β-glucosidase activities connected with detrimental effects in the gastrointestinal tract and together no amino acid decarboxylase activities and no genes associated with biogenic amines production though only chicken L. salivarius 15K whole cells and acid supernatants shown strong suppressive potential against biofilm-forming Klebsiella and Escherichia coli. Our results highlight that above-mentioned isolate L. salivarius 15K fulfils the principle requirements of a qualified probiotic and may be seen as a reliable candidate for further validation studies in chicken.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibiotic resistance; Escherichia coli; Klebsiella; Lactobacilli; Maldi-Tof MS; β-Glucuronidase

Mesh:

Substances:

Year:  2013        PMID: 24291759     DOI: 10.1016/j.anaerobe.2013.10.009

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  11 in total

1.  Probiotic potential of lactobacillus strains isolated from sorghum-based traditional fermented food.

Authors:  K Poornachandra Rao; G Chennappa; U Suraj; H Nagaraja; A P Charith Raj; M Y Sreenivasa
Journal:  Probiotics Antimicrob Proteins       Date:  2015-06       Impact factor: 4.609

2.  In vitro properties of potential probiotic lactic acid bacteria originating from Ghanaian indigenous fermented milk products.

Authors:  Grace Adzo Motey; James Owusu-Kwarteng; Kwasi Obiri-Danso; Linda Aurelia Ofori; William Otoo Ellis; Lene Jespersen
Journal:  World J Microbiol Biotechnol       Date:  2021-02-17       Impact factor: 3.312

Review 3.  Insights in the Development and Uses of Alternatives to Antibiotic Growth Promoters in Poultry and Swine Production.

Authors:  Md Ramim Tanver Rahman; Ismail Fliss; Eric Biron
Journal:  Antibiotics (Basel)       Date:  2022-06-02

4.  Innovative Use of Olive, Winery and Cheese Waste By-Products as Functional Ingredients in Broiler Nutrition.

Authors:  Eleftherios Bonos; Ioannis Skoufos; Konstantinos Petrotos; Ioannis Giavasis; Chrysanthi Mitsagga; Konstantina Fotou; Konstantina Vasilopoulou; Ilias Giannenas; Evangelia Gouva; Anastasios Tsinas; Angela Gabriella D'Alessandro; Angela Cardinali; Athina Tzora
Journal:  Vet Sci       Date:  2022-06-12

5.  Probiotic properties of novel probiotic Levilactobacillus brevis KU15147 isolated from radish kimchi and its antioxidant and immune-enhancing activities.

Authors:  Kee-Tae Kim; Seo Jin Yang; Hyun-Dong Paik
Journal:  Food Sci Biotechnol       Date:  2021-01-06       Impact factor: 2.391

Review 6.  Probiotic isolates from unconventional sources: a review.

Authors:  Pairat Sornplang; Sudthidol Piyadeatsoontorn
Journal:  J Anim Sci Technol       Date:  2016-07-19

7.  Development of putative probiotics as feed additives: validation in a porcine-specific gastrointestinal tract model.

Authors:  Soyoung Yeo; Suro Lee; Hyunjoon Park; Heuynkil Shin; Wilhelm Holzapfel; Chul Sung Huh
Journal:  Appl Microbiol Biotechnol       Date:  2016-09-15       Impact factor: 4.813

8.  Assessing the Risk of Probiotic Dietary Supplements in the Context of Antibiotic Resistance.

Authors:  Min Zheng; Ruijia Zhang; Xuechen Tian; Xuan Zhou; Xutong Pan; Aloysius Wong
Journal:  Front Microbiol       Date:  2017-05-19       Impact factor: 5.640

9.  Effects of the Food Manufacturing Chain on the Viability and Functionality of Bifidobacterium animalis through Simulated Gastrointestinal Conditions.

Authors:  Pattra Charnchai; Sirima Suvarnakuta Jantama; Chutinun Prasitpuriprecha; Sunthorn Kanchanatawee; Kaemwich Jantama
Journal:  PLoS One       Date:  2016-06-22       Impact factor: 3.240

10.  Isolation, Molecular Characterization and Probiotic Potential of Lactic Acid Bacteria in Saudi Raw and Fermented Milk.

Authors:  Maged S Bin Masalam; Ahmed Bahieldin; Mona G Alharbi; Saad Al-Masaudi; Soad K Al-Jaouni; Steve M Harakeh; Rashad R Al-Hindi
Journal:  Evid Based Complement Alternat Med       Date:  2018-07-25       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.